期刊文献+

新蝶呤在冠心病中的作用 被引量:1

下载PDF
导出
摘要 巨噬细胞在动脉粥样硬化的发生、发展和斑块破裂中发挥重要作用,新蝶呤是巨噬细胞激活的特定产物,对冠心病各表型的预后有独立预测作用,降低新蝶呤对冠心病的防治有一定价值。
出处 《国际心血管病杂志》 2007年第3期156-159,共4页 International Journal of Cardiovascular Disease
  • 相关文献

参考文献17

  • 1[1]Berdowska A,Zwirska-Korczala K.Neopterin measurement in clinical iagnosis[J].J Clin Pharm Ther,2001,26(5):319-329.
  • 2[2]Wirleitner B,Reider D,Ebner S,et al.Monocyte-derived dendritic cells release neopterin[J].J Leukoc Biol,2002,72(6):1148-1153.
  • 3[3]Ueland T,Vissers MN,Wiegman A,et al.Increased inflammatory markers in children with familial hypercholesterolaemia[J].Eur J Clin Invest,2006,36(3):147-152.
  • 4[4]Avanzas P,Arroyo-Espliguero R,Cosin-Sales J,et al.Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease[J].Am J Cardiol,2004,93(5):627-629.
  • 5[5]Garcia-Moll X,Cole D,Zouridakis E,et al.Increased serum neopterin:a marker of coronary artery disease activity in women[J].Heart,2000,83(3);346-350.
  • 6[6]Avanzas P,Arroyo-Espliguero R,Quiles J,et al.Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris[J].Eur Heart J,2005,26(5):457-463.
  • 7[7]Zouridakis E,Avanzas P,Arroyo-Espliguero R,et al.Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris[J].Circulation,2004,110(13):1747-1753.
  • 8[8]Garcia-Moll X,Coccolo F,Cole D,et al.Serum neopterin and complex stenosis morphology in patients with unstable angina[J].J Am Coll Cardiol,2000,35(4):956-962.
  • 9[9]Avanzas P,Arroyo-Espliguero R,Cosin-Sales J,et al.Markers of inflammation and multiple complex stenooses(pancoronary plaque vulnerability)in patients with non-ST segment elevation acute coronary syndromes[J].Heart,2004,90(8):847-852.
  • 10[10]Schumacher M,Halwachs G,Tatzber F,et al.Increased neopterin in patients with chronic and acute coronary syndromes[J].J Am Coil Cardiol,1997,30(3):703-707.

同被引文献17

  • 1姜霞,田凤石,熊湘明,吕锦,王金良,许静,卢凤民.血清新蝶呤对冠心病患者的临床诊断价值[J].天津医药,2005,33(5):257-259. 被引量:6
  • 2姚泰.生理学[M].北京:人民卫生出版社,2003.75-135.
  • 3陈灏珠,丁训杰,廖履坦,等.实用内科学[M].北京:人民卫生出版社,2013:1556.
  • 4Avanzas P, Kaski JC. Neopterin for risk assessment in angina pectoris[J]. Drug News Perspect, 2009, 22 ( 4 ) : 215-219.
  • 5Huber C, Batchelor JR, Fuchs D, et al. Immune response-associated production of neopterin.Release from macrophages primarily under control of interferon-gamma[J]. J Exp Med, 1984, 160 ( 1 ) : 310- 316.
  • 6Murr C,Widner B,Wirleimer B,et al.Neopterin as a market for immune system activation[J]. Curt Drug Metab, 2002, 3 ( 2 ) : 175- 187.
  • 7Mahmound R.A, Elendi HI, Abmed HH. Serum neopterin.Tumor necrpsis factor-alpha and soluble tumor necrosis factor recepotor II levels and disease activity in Egyptian female with systemic lupus erythematosus[J]. Clin Biochem, 2005, 38 (2) : 134-141.
  • 8Tousoulis D, Kampoli AM, Stefanadi E, et al. New biochemical markers in acute coronary syndromes[J]. Curr Med Chem, 2008, 15 ( 13 ) : 1288-1296.
  • 9Chalela J A. Evaluating the carotid plaque : going beyond stenosis[J]. Cerebrovasc, 2009, 27 ( suppl 1 ) : 19-24.
  • 10Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient : a call for new definitions and risk assessment strategies : Part I[J]. Circulation, 2003, 108 ( 14 ) : 1664-1672.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部